GLADYS CHI: Open Payments
NPI 1215260476 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$119 in 5 payments from 3 companies in 2025. Trend: 2023 $154 · 2024 $187 · 2025 $119
Food & beverage: $119
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $77 |
| SANOFI-AVENTIS U.S. LLC | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: ZEPBOUND, TZIELD, MOUNJARO, SHINGRIX.
Industry payments across DC — which companies pay providers there.
